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Abstract
Background: The Digestive Diseases Week (DDW) is the major meeting for presentation of
research in gastroenterology. The acceptance of an abstract for presentation at this meeting is the
most important determinant of subsequent full publication. We wished to examine the
determinants of abstract acceptance for this meeting.
Methods: A cross-sectional study was performed, based on abstracts submitted to the DDW. All
17,205 abstracts submitted from 1992 to 1995 were reviewed for acceptance, country of origin
and research type (controlled clinical trials (CCT), other clinical research (OCR), basic science
(BSS)). A random sub-sample (n = 1,000) was further evaluated for formal abstract quality,
statistical significance of study results and sample size.
Results: 326 CCT, 455 OCR and 219 BSS abstracts were evaluated in detail. Abstracts from N/
W Europe (OR 0.4, 95% CI 0.3–0.6), S/E Europe (OR 0.4, 95% CI 0.2–0.6) and non-Western
countries (OR 0.3, 95% CI 0.2–0.5) were less likely to be accepted than North-American
contributions when controlling for research type. In addition, the OR for the acceptance for studies
with negative results as compared to those with positive results was 0.4 (95% CI 0.3–0.7). A high
abstract quality score was also weakly associated with acceptance rates (OR 1.4, 95% CI 1.0–2.0).
Conclusions: North-American contributions and reports with statistically positive results have
higher acceptance rates at the AGA. Formal abstract quality was also predictive for acceptance.
Background
The annual Digestive Disease Week (DDW) is an impor-
tant opportunity for the presentation of research in gastro-
enterology, attracting investigators and clinicians from
around the world. Every year, several thousand abstracts
are submitted to this meeting which is jointly organized
by the American Gastroenterological Association (AGA),
the American Association for the Study of Liver Diseases
(AASDL), the American Society for Gastrointestinal En-
doscopy (ASGE) and the Surgical Society for the Alimen-
tary Tract (SSAT). Only about one half of these submitted
abstracts will eventually be published as full papers, a rate
comparable to other medical meetings (A Timmer, RJ
Hilsden, J Cole, D Hailey and LR Sutherland, unpub-
lished data, 2001) [1–4].
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From surveys on unpublished research there is evidence
that the failure to publish is, in the majority of cases, due
to non-submission rather than to manuscript rejection
[4,5]. Several studies have shown that abstract acceptance
at a scientific meeting significantly influences the decision
to write up and submit a complete manuscript for publi-
cation [4,6–8]. However, given the importance of meeting
reports in scientific communication, the determinants of
abstract acceptance are understudied [9]. While expert re-
view processes aim at selecting abstracts based on the po-
tential scientific impact of a contribution, other factors
which are not easily identified during the usual review
process also play a role.
A factor of particular concern is the potential for preferen-
tial acceptance of studies with statistically significant re-
sults as compared to "negative" results. Positive outcome
bias in the publication process ("publication bias"), has
been acknowledged as a problem primarily in the context
of meta-analysis of published clinical trials [10,11]. How-
ever, this phenomenon is suspected to apply to any type
of research, and may be even more prominent in observa-
tional or in less rigorously controlled interventional de-
signs [5].
Other potential determinants of abstract acceptance other
than the scientific impact include the origin of the ab-
stract, the research type, and the formal abstract quality,
including the quality of the language. Therefore, given the
influence of abstract acceptance on subsequent publica-
tion and the lack of research on this issue, the objective of
this study was to identify the determinants of abstract ac-
ceptance for the DDW.
Materials and methods
All abstracts submitted to the DDW between 1992 to
1995 (inclusive), including those rejected for presentation
at the meeting, were screened for research type, country of
origin and acceptance for presentation. These abstracts are
available in print from the annual abstract volume of Gas-
troenterology. Country of origin was based on the affilia-
tion of the first author as reported in the abstract. Research
type was categorized as controlled clinical trial (CCT),
other clinical research (OCR) or basic science study (BSS).
CCT accounted for about 5% of all submissions, and com-
prised all clinical trials where a controlled parallel or
cross-over design was used. In other words, besides Phase
III clinical trials, controlled Phase II and Phase IV studies
were included in this group [12]. OCR reports comprised
therapeutic/diagnostic studies (i.e. studies other than
CCT, examining the effects of therapeutic or diagnostic
procedures), epidemiologic research (i.e. studies assessing
frequencies of disease states or risk factors for their occur-
rence), and physiologic studies in humans, i.e. studies de-
voted to the elucidation of disease processes in men,
healthy or diseased. BSS were defined as any study, per-
formed in a laboratory setting, where the unit of analysis
was not the intact human (animal studies, and studies in
biological material). Abstracts that did not report empiri-
cal data or that could not be classified as clinical research
or basic science studies were excluded. A random sample
of 1,000 abstracts was selected based on computer-gener-
ated random numbers. Since we considered positive out-
come bias and aspects of formal quality to be particularly
relevant in CCT, we used a disproportionately stratified
sampling procedure based on research type to increase the
proportion of CCT in the sample (n = 400). The examina-
tion of abstract characteristics in BSS had a more explora-
tory character. Therefore, a smaller proportion of BSS was
sampled (n = 200, OCR: n = 400). The sampling was also
stratified by year of submission.
All sample abstracts were evaluated in random order by a
single observer (AT) who was blinded to abstract authors,
affiliations and acceptance status. The research type (CCT,
OCR, or BSS) was reviewed, and revised where necessary.
To detect any systematic errors during the abstract assess-
ment, of every 100 consecutively evaluated abstracts, 10%
were evaluated a second time by the same investigator fol-
lowing an interval of 4–6 weeks (test-retest reliability). An
additional 10% were evaluated by a second reviewer
(RJH), and the two ratings were tested for inter rater agree-
ment. Items recorded were study design, sample size, sta-
tistical significance of study results and formal abstract
quality.
Formal abstract quality was defined as a combination of
the completeness of reporting and the internal validity of
the study. Because no measurement instrument was avail-
able that would enable a uniform approach across the
large variety of research types, designs and topics, a rating
system was developed based on previously validated qual-
ity scoring instruments for full papers [13,14] with modi-
fications based on recommendations for the reporting of
structured abstracts [15,16]. In this rating system, items
such as the definition of a research objective, the reporting
and appropriateness of the statistical methods, the appro-
priateness of the sample size, and (where applicable) sub-
ject selection criteria, use of control groups, use of
randomization, blinding, and control of confounding are
combined into a single summary score. The instrument is
described in more detail in a separate manuscript which
has been submitted for publication. Quality of language
was assessed separately by native speakers of North Amer-
ican English currently working in the field of gastroenter-
ology. It was graded as "none or minor errors" (such as
typographical errors) or "major errors" (such as grammat-
ical errors or inappropriate vocabulary).BMC Medical Research Methodology 2001, 1 http://www.biomedcentral.com/1471-2288/1/13
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Sample size was recorded as the number of subjects per
treatment arm or study group. The distributions of sample
size and formal abstract quality score were assessed sepa-
rately for the three different research types. Within each
type, the variables were categorized into tertiles.
Large sample size was defined as a sample size within the
highest tertile. Similarly, high formal abstract quality was
defined by a formal quality score within the highest tertile
of summary scores.
Statistical significance of the results was assumed if p <
0.05 with respect to the main outcome, if the 95% confi-
dence interval (95% CI) excluded the reference value, or if
the report stated that statistical significance was achieved.
Results were considered negative when statistical signifi-
cance was not achieved. Results were considered "equivo-
cal" when statements on statistical significance were
absent or when multiple results with mixed significance
were reported.
Abstract productivity of a country was defined as the
number of submitted abstracts per 1,000 physicians in the
country, based on published statistical information on
population size and physician density [17]. Countries
were grouped after data exploration, depending on simi-
larities in the distribution of research type, acceptance
rates and geographical region.
Statistical analysis
For the assessment of test-retest and inter rater reliability
of the rating system, intra class correlation coefficients
(ICCC) were calculated [18].
The sample size was calculated to allow for separate anal-
yses by research type (controlled clinical trials, other clin-
ical research, basic science research), to detect a minimum
relevant OR of 2.0 with a power of > 80%. Multiple logis-
tic regression was used to calculate adjusted odds ratios
for abstract acceptance. Chi squared tests and Spearman's
correlation coefficient were used in the explorative analy-
sis. Statistical significance was assumed on a 95% level of
confidence. Publication rates are presented stratified by
research type, statistical significance of the abstract results,
and region of origin.
Determinants of abstract acceptance were estimated using
multiple logistic regression analysis, including only ana-
lytical studies (studies including a control group or be-
fore-after comparisons). To account for the
disproportionate sampling, analyses were performed
stratified by research type (separate models for each
group). In a combined model, effects of interaction were
examined by the inclusion of interaction terms. All data
were entered as categorical variables. Model fit was exam-
ined by the Hosmer-Lemeshow-test [19].
Table 1: Distribution and crude acceptance by country of origin, all abstracts
Country Number submitted Research type Number accepted (%)
CCT OCR BSS
1. USA 7,406 3.3% 39.8% 56.1% 5377 (72.6)
2. Japan 1,636 0.9% 26.4% 64.9% 762 (46.6)
3. Germany 1,308 7.6% 49.8% 42.3% 771 (58.9)
4. UK 1,161 8.2% 58.4% 33.1% 697 (60.0)
5. Italy 994 7.7% 74.8% 17.0% 437 (44.0)
6. France 944 9.9% 61.3% 28.5% 522 (55.3)
7. Canada 765 4.8% 26.4% 67.8% 530 (69.3)
8. Netherlands 443 7.7% 63.0% 28.9% 265 (59.8)
9. Australia 317 6.6% 51.7% 41.0% 213 (67.2)
10. Belgium 254 3.5% 62.6 % 32.7% 150(59.1)
11. Spain 245 8.6% 55.9 % 35.5% 128 (52.2)
12. Switzerland 207 14.5% 58.0 % 27.1% 140 (67.6)
13. Ireland 184 4.3% 67.4 % 28.3% 90 (48.9)
14. Sweden 173 11.6% 29.5 % 58.4% 102 (59.0)
15.-65. othera 1168 10.4% 54.6 % 34.2% 520 (44.5)
Total 17,205 5.4% 46.7% 47.4% 10,704(62.2)
aAll countries submitting < 150 abstracts/4 yearsBMC Medical Research Methodology 2001, 1 http://www.biomedcentral.com/1471-2288/1/13
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Results
Description of abstracts and acceptance rates, all ab-
stracts
During the four year period, 17,205 abstracts were sub-
mitted. Contributions were divided approximately evenly
between clinical and basic science research (Table 1).
Only 5.4% of all abstracts were CCT. The percentage of
unclassifiable studies was below 1%.
Abstracts were submitted from 65 different countries.
However, the top 10 contributors accounted for 90% of
all submitted abstracts. Thirty nine percent of the abstracts
originated in the US, followed by Japan (10%) and Ger-
many (8%). In 503 abstracts (2.9%), authors from more
than one country were reported. Taking into account pop-
ulation size and physician density, Irish investigators were
the most productive, with an average of 9.0 submissions
per 103 physicians per year (2nd Canada, 3.1/103, 3rd UK,
3.1/103).
The overall acceptance rate was 62.2% and varied by re-
search type (CCT 66.9%, OCR 56.3%, BSS 70.5%). Inter-
national contributions were more often accepted than
those involving only one country (73.8% vs. 61.9%).
Crude acceptance rates for the top 10 contributor coun-
tries by country of first author are presented in Table 1.
There were no substantial changes in acceptance rates by
country when the analysis was based on the country of the
last author as compared to the country of the first author.
Description of sample abstracts
After revision of the research type, overall, 326 CCT, 455
OCR and 219 BSS were included in the random sample
and evaluated in more detail. The evaluation procedure
was found to be consistent over time (test-retest reliabili-
ty, ICCC 0.85) and between the two raters (inter rater re-
liability, ICCC 0.69). The abstract characteristics are
shown in Table 2. OCR studies were evenly divided be-
tween therapeutic or diagnostic studies (T&D, n = 159),
epidemiology (epid., n = 135) and human physiology
(physiol., n = 161). Within these subgroups, there was no
difference in acceptance rates or in the percentage of neg-
ative studies (overall 12%). It is of note that only 4% of
BSS reported negative results (CCT: 30%). Negative results
were associated with lower sample size in CCT (p = 0.04)
but not in OCR or BSS/animal studies (p = 0.6 and p =
0.8). There were no differences in the distribution of sam-
ple size categories based on region when stratified by re-
search type (p = 0.3). Major language errors occurred in
7% of the abstracts (US/Canada 2%, N/W-Europe 9%, S/
E-Europe 12%, other 11%). Comprehensibility was com-
promised by language errors in < 1% of the abstracts.
Table 2: Distribution and baseline characteristics of sample abstracts
CCT OCR BSS Total
Total 326 455 219 1,000
analytical design 326(100%) 331(73%) 174(79%) 831 (83%)
descriptive design - 124 (27%) 45 (21%) 169(17%)
Country region
US/Canada 88 (27%) 181 (40%) 121 (55%) 390 (39%)
NW-Europe/Austr. 138(42%) 135 (30%) 44 (20%) 317(32%)
SE-Europe 52(16%) 62 (14%) 9 (4%) 123 (13%)
other 48(15%) 77(17%) 45 (21%) 170 (17%)
Language
no or minor errors 301 (92%) 416(91%) 210(96%) 927 (93%)
major errors 25 (8%) 39 (8%) 9 (4%) 73 (7%)
Median sample size/group
subtype 1 parallel: 30 T & D: 22 animal: 6
subtype 2 cross over: 10 epid.: 38 other: n/a
subtype 3 physiol: 10
Quality score
median 0.66 0.52 0.51
IQR 0.62–0.70 0.44–0.58 0.44–0.57
Stat. significancea
positive 140 (43%) 149 (45%) 65 (37%) 354 (42%)
negative 99 (30%) 41 (12%) 7 (4%) 147(18%)
equivocal 87 (27%) 141 (43%) 102 (59%) 330 (40%)
aanalytical studies onlyBMC Medical Research Methodology 2001, 1 http://www.biomedcentral.com/1471-2288/1/13
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Predictors of abstract acceptance, sample abstracts
The region of origin was associated with acceptance rates
for all research types. The statistical significance and the
formal quality were significantly associated with abstract
acceptance in CCT and OCR but not in BSS (Table 3). The
strong association between abstract origin and acceptance
rates was not explained by differences in formal quality
(Table 4). Abstracts containing major errors were on crude
analysis less likely to be accepted than abstracts with no or
minor errors (52.1% vs. 64.2%, p = 0.06). However, when
stratified by region, this effect disappeared (p = 0.7). Fur-
thermore, the association between origin and acceptance
rates was sustained when abstracts with major language
errors were excluded from the analysis.
Logistic regression analysis for the sample abstracts con-
firmed country region of origin, statistical significance of
the results and study type as significant predictors of ab-
stract acceptance (Table 5). Contributions from North
America were more likely to be accepted when compared
with submissions from Europe or other countries, and
this effect was independent of the inclusion of other vari-
ables. Reports with negative results were less likely to be
accepted as compared to studies with positive results, and
BSS were less likely to be accepted than clinical research.
As to be suspected from the stratified analysis, language
errors were not associated with reduced chances for ac-
ceptance after controlling for other variables. No effect
was found for one vs. two or more countries (national vs.
international studies), and for sample size. Interaction be-
tween research type and statistical significance of the
study results or origin could not be demonstrated by the
inclusion of product terms.
Estimates from a model restricted to CCT were of similar
strength as those of the overall model, with the statistical
significance and formal abstract quality being significant-
ly associated with abstract acceptance. In addition, the use
of parallel controls as opposed to cross over designs con-
tributed significantly to the prediction of acceptance. Dif-
ferences based on the country of origin were apparent;
however, confidence intervals included the reference val-
ue.
For OCR, country of origin, statistical significance of the
study results and formal abstract quality were significantly
associated with acceptance. In BSS, the gradient based on
the origin of the abstract was particularly strong as com-
pared to the other sub-models. Animal studies had lower
acceptance rates than studies in biological material.
The inclusion of formal quality as a continuous score rath-
er than a dichotomized variable increased the precision of
the models. Due to the narrower confidence intervals in
this approach, country of origin was a significant predic-
tor of abstract acceptance in all submodels. Otherwise, no
substantially different results were found. The point esti-
mates were similar as compared to the models using only
categorical variables.
Table 3: Acceptance rates by region, statistical significance and 
formal quality
CCT OCR BSS
Total number accepted (%)a 227 (69.6) 214(63.7) 101 (58.0)
Statistical significance
negative 58 (58.6) 25(61.0) 3 (42.9)
positive 108(77.1) 108 (72.5) 37 (56.9)
equivocal 61 (70.1) 81 (55.5) 61 (59.8)
Country region
US/Canada 70 (79.5) 97 (75.8) 67 (70.5)
NW-Europe/Australia 90 (65.2) 60(56.1) 18(52.9)
SE-Europe 38(73.1) 22 (50.0) 4 (44.4)
other 29 (60.4) 35(61.4) 12(33.3)
Quality score
lowest tertile 69(61.1) 47(51.1) 31 (57.4)
median 71 (67.0) 77 (65.3) 35 (62.5)
highest tertile 87(81.3) 90(71.4) 35 (54.7)
aacceptance rates may differ from those reported above due to the 
exclusion of descriptive studies
Table 4: Acceptance rates by region, stratified by formal quality
low score medium score high score
N (%) N (%) N (%)
US/Canada 91 62 (68.1) 113 86 (76.1) 107 86 (80.4)
NW-Europe/Australia 78 43 (55.1) 93 54 (58.1) 108 71 (65.7)
SE-Europe 33 17 (51.5) 36 20 (55.6) 36 27 (75.0)
other 57 25 (43.9) 38 23 (60.5) 46 28 (60.9)BMC Medical Research Methodology 2001, 1 http://www.biomedcentral.com/1471-2288/1/13
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Discussion
This study identified two possible areas of bias in the
process of abstract selection for the annual DDW: a bias in
favor of North-American contributions, and a bias based
on the statistical significance of the results.
Bias based on national origin has been reported in various
aspects of the dissemination and appreciation of research,
e.g. with respect to citation-publication ratios, journals'
peer review processes, inclusion of trials into meta-analy-
sis and even the distribution of Nobel prizes [20–27]. In
our study, the association between the origin of the ab-
stract and the chance for presentation at the meeting was
strong and consistent across research types and formal
quality categories, although there is an impression that
the association is more pronounced in BSS as opposed to
CCT. The lack of statistical significance for country of ori-
gin in the model restricted to CCT is most likely due to a
type II error. The variable became significant when formal
quality was entered as a continuous variable, increasing
the precision of the estimates. The proportion of abstracts
with major language errors was too low to have a signifi-
cant impact on acceptance rates. The finding of country
bias is in contrast to the results of a similar study which
has recently been published in Gastrointestinal Endoscopy
by Eloubeidi et al [28]. In this study, the determinants of
publication and abstract acceptance were examined based
on abstracts submitted to the American Society for Gas-
trointestinal Endoscopy. No effect was found for country
of origin (US vs. non US) with respect to abstract accept-
ance for the meeting. However, these abstracts represent-
ed a very limited area of gastroenterology and comprised
almost exclusively clinical research. Also, almost all of the
non US submissions were of North-West European origin,
while at the DDW, Japan was the second most frequent
country of origin. Of note, in the study by Eloubeidi, non
US submissions were followed by full publications in a
significantly higher proportion as compared to abstracts
from the United States. Possibly, there are European cent-
ers which are particularly strong in endoscopy research.
The low subsequent full publication rate in the study by
Eloubeidi (25%) is in contrast to publication rates pub-
lished for other medical specialities (most often around
50% [3]) and may indicate that the results are not repre-
sentative of more general meetings.
A limitation of our study was the inability to take into ac-
count originality and relevance which can only be as-
sessed by expert reviewers. However, experts cannot be
unaware to the origin of the abstracts, even if, other than
in the DDW review process, attempts for blinding were
made. It has been shown that abstract reviewers were able
to correctly guess the responsible research lab in about
40% of submissions in blinded review [29,30]. Also, in-
ter-rater reliability has been shown to be poor among ex-
pert reviewers [9,31]. Bias based on the identity, the
origin, or the affiliation of an author can thus never be
completely excluded in expert peer review. On the other
hand, the scientific impact of a contribution can not be
consistently gauged over a heterogeneous set of research.
We would suggest the two approaches (expert review vs.
formal assessment) are complementary.
We found evidence for publication bias, i.e. for preferen-
tial acceptance of abstracts with positive results, which
was demonstrated for clinical trials as well as for "other
clinical research". As well, the very low proportion of neg-
ative outcome reports in BSS (4%), may represent another
form of positive outcome bias at the pre-submission stage.
Publication bias is particularly important and well dem-
onstrated in meta-analyses of clinical trials or of studies
on causality [32–34]. The effects of positive outcome bias
in the selection procedures of scientific meetings, a phe-
nomenon described before for other societies [4,35], may
be more insidious, and possibly no less damaging, e.g. in
view of the role of abstract acceptance as possibly the most
important predictor of subsequent publication [4,6–8].
Potential reasons for lack of statistical significance may be
inappropriate sample size or premature reporting of on-
going studies – both should rightly decrease the chances
for acceptance. On the other hand, even if sufficient pow-
er (of ≥  0.80) and a truly present effect was assumed for all
studies, at least 20% of the reports should be expected to
Table 5: Predictors of abstract acceptance (n = 831a, adjusted for 
year of submission)
n OR 95% CI
Research type
CCT 326 1
OCR 331 0.6 0.5–0.9
BSS 174 0.4 0.3–0.7
Statistical significance
positive 350 1
negative 147 0.5 0.3–0.8
equivocal 334 0.7 0.5–0.9
Abstract quality score
lowest or middle tertile 532 1
highest tertile 299 1.4 1.0–2.0
Country group
USA/Canada 305 1
N/W Europe, Australia 291 0.4 0.3–0.6
S/E Europe 102 0.4 0.2–0.6
other countries 143 0.3 0.2–0.5
Model χ 2 62.1 (df8), p < .0001; Hosmer and Lemeshow Test:c2 9.3 
(df8), p = 0.2 aexcluded from the analysis: all descriptive studies (n = 
169)BMC Medical Research Methodology 2001, 1 http://www.biomedcentral.com/1471-2288/1/13
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show negative results. Given the very low medians for
sample size (Table 2), it is the more surprising how low
the proportion of submitted negative studies was, even in
CCT. There seems to be, in addition to the bias shown for
abstract acceptance, a significant preference for statistical-
ly significant results influencing abstract submission.
A more reassuring finding in our study was the impor-
tance of formal abstract quality for abstract acceptance for
the DDW. This is in accordance with the findings of other
investigators who came to the conclusion that how one
writes is at least as important as what one writes, or that atten-
tion to form reflects attention to content [36]. Possibly,
formal quality is most important, as well as most easily as-
sessed in CCT. The rating system we used is less responsive
in BSS due to the lower number of applicable items. For-
mal abstract quality could in fact not be shown to be asso-
ciated with abstract acceptance in this group. On the other
hand, frequent omissions included basic, essential items
such as the definition of a research objective or the
number of animals studied. The lack of association with
abstract acceptance indicates that formal requirements are
considered to be less important in this type of research.
Therefore, insufficient control for confounding by formal
quality is unlikely to explain the preferential acceptance
by country of origin which was particularly strong in BSS.
Another potential limitation of our study is the inability
to adequately control for sample size, as this can not be di-
rectly compared across different designs and research
questions. Lastly, one needs to acknowledge that we ex-
amined associations in an observational design. Causal
inference must, therefore, be drawn with caution. An ex-
perimental design such as presenting sets of identical ab-
stracts modifying only certain variables, such as the
identity of the author, or the statistical significance of the
study results, would be helpful to further substantiate the
findings. Such an experiment has for example been per-
formed to test the peer review process in the educational
sciences, and clear evidence for confirmatory bias (i.e. the
tendency to prefer experiences which confirm the ideas of
the reviewer) was found [37].
In conclusion, in the DDW abstract review process there is
a remarkable preference for abstracts of North-American
origin, and for abstracts presenting statistically significant
results. More research is needed to further elucidate the
underlying mechanisms.
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